Prognosis for patients with carcinoma in the middle third of the stomach

Hideaki Anai, Yoshihiko Maehara, Tatsuo Oshiro, Hideo Baba, Hiroyuki Orita, Toshiro Okuyama, Keizo Sugimachi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In 268 of the 1,115 patients (24.0%) with gastric cancer who underwent a curative resection in our clinics, the tumor was located in the middle third of the stomach. The clinicopathological features and prognosis of these patients were divided into two groups, according to site of the tumor: anterior wall (n = 58) vs. other sites (n = 210). Clinicopathological factors did not differ between the two groups. The survival time for patients with a tumor in the anterior group was shorter than that for patients with a tumor in other areas (P < 0.05). The five‐year survival rate was 79.3% for patients with an anterior tumor and 91.9% for those with a tumor at a different site. A multivariate analysis indicated lymph node metastasis, serosal invasion, and anterior wall location to be independent prognostic factors indicative of a poor prognosis when the tumor was located in the middle third of the stomach. For such patients, close follow‐up is needed to detect possible recurrences. © 1993 Wiley‐Liss, Inc.

Original languageEnglish
Pages (from-to)204-207
Number of pages4
JournalJournal of Surgical Oncology
Volume53
Issue number3
DOIs
Publication statusPublished - Jan 1 1993

Fingerprint

Stomach
Carcinoma
Neoplasms
Stomach Neoplasms
Multivariate Analysis
Survival Rate
Lymph Nodes
Neoplasm Metastasis
Recurrence
Survival

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Anai, H., Maehara, Y., Oshiro, T., Baba, H., Orita, H., Okuyama, T., & Sugimachi, K. (1993). Prognosis for patients with carcinoma in the middle third of the stomach. Journal of Surgical Oncology, 53(3), 204-207. https://doi.org/10.1002/jso.2930530316

Prognosis for patients with carcinoma in the middle third of the stomach. / Anai, Hideaki; Maehara, Yoshihiko; Oshiro, Tatsuo; Baba, Hideo; Orita, Hiroyuki; Okuyama, Toshiro; Sugimachi, Keizo.

In: Journal of Surgical Oncology, Vol. 53, No. 3, 01.01.1993, p. 204-207.

Research output: Contribution to journalArticle

Anai, H, Maehara, Y, Oshiro, T, Baba, H, Orita, H, Okuyama, T & Sugimachi, K 1993, 'Prognosis for patients with carcinoma in the middle third of the stomach', Journal of Surgical Oncology, vol. 53, no. 3, pp. 204-207. https://doi.org/10.1002/jso.2930530316
Anai H, Maehara Y, Oshiro T, Baba H, Orita H, Okuyama T et al. Prognosis for patients with carcinoma in the middle third of the stomach. Journal of Surgical Oncology. 1993 Jan 1;53(3):204-207. https://doi.org/10.1002/jso.2930530316
Anai, Hideaki ; Maehara, Yoshihiko ; Oshiro, Tatsuo ; Baba, Hideo ; Orita, Hiroyuki ; Okuyama, Toshiro ; Sugimachi, Keizo. / Prognosis for patients with carcinoma in the middle third of the stomach. In: Journal of Surgical Oncology. 1993 ; Vol. 53, No. 3. pp. 204-207.
@article{e71e30e1c4054ce1aec1be57bf33dfac,
title = "Prognosis for patients with carcinoma in the middle third of the stomach",
abstract = "In 268 of the 1,115 patients (24.0{\%}) with gastric cancer who underwent a curative resection in our clinics, the tumor was located in the middle third of the stomach. The clinicopathological features and prognosis of these patients were divided into two groups, according to site of the tumor: anterior wall (n = 58) vs. other sites (n = 210). Clinicopathological factors did not differ between the two groups. The survival time for patients with a tumor in the anterior group was shorter than that for patients with a tumor in other areas (P < 0.05). The five‐year survival rate was 79.3{\%} for patients with an anterior tumor and 91.9{\%} for those with a tumor at a different site. A multivariate analysis indicated lymph node metastasis, serosal invasion, and anterior wall location to be independent prognostic factors indicative of a poor prognosis when the tumor was located in the middle third of the stomach. For such patients, close follow‐up is needed to detect possible recurrences. {\circledC} 1993 Wiley‐Liss, Inc.",
author = "Hideaki Anai and Yoshihiko Maehara and Tatsuo Oshiro and Hideo Baba and Hiroyuki Orita and Toshiro Okuyama and Keizo Sugimachi",
year = "1993",
month = "1",
day = "1",
doi = "10.1002/jso.2930530316",
language = "English",
volume = "53",
pages = "204--207",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Prognosis for patients with carcinoma in the middle third of the stomach

AU - Anai, Hideaki

AU - Maehara, Yoshihiko

AU - Oshiro, Tatsuo

AU - Baba, Hideo

AU - Orita, Hiroyuki

AU - Okuyama, Toshiro

AU - Sugimachi, Keizo

PY - 1993/1/1

Y1 - 1993/1/1

N2 - In 268 of the 1,115 patients (24.0%) with gastric cancer who underwent a curative resection in our clinics, the tumor was located in the middle third of the stomach. The clinicopathological features and prognosis of these patients were divided into two groups, according to site of the tumor: anterior wall (n = 58) vs. other sites (n = 210). Clinicopathological factors did not differ between the two groups. The survival time for patients with a tumor in the anterior group was shorter than that for patients with a tumor in other areas (P < 0.05). The five‐year survival rate was 79.3% for patients with an anterior tumor and 91.9% for those with a tumor at a different site. A multivariate analysis indicated lymph node metastasis, serosal invasion, and anterior wall location to be independent prognostic factors indicative of a poor prognosis when the tumor was located in the middle third of the stomach. For such patients, close follow‐up is needed to detect possible recurrences. © 1993 Wiley‐Liss, Inc.

AB - In 268 of the 1,115 patients (24.0%) with gastric cancer who underwent a curative resection in our clinics, the tumor was located in the middle third of the stomach. The clinicopathological features and prognosis of these patients were divided into two groups, according to site of the tumor: anterior wall (n = 58) vs. other sites (n = 210). Clinicopathological factors did not differ between the two groups. The survival time for patients with a tumor in the anterior group was shorter than that for patients with a tumor in other areas (P < 0.05). The five‐year survival rate was 79.3% for patients with an anterior tumor and 91.9% for those with a tumor at a different site. A multivariate analysis indicated lymph node metastasis, serosal invasion, and anterior wall location to be independent prognostic factors indicative of a poor prognosis when the tumor was located in the middle third of the stomach. For such patients, close follow‐up is needed to detect possible recurrences. © 1993 Wiley‐Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0027182050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027182050&partnerID=8YFLogxK

U2 - 10.1002/jso.2930530316

DO - 10.1002/jso.2930530316

M3 - Article

VL - 53

SP - 204

EP - 207

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -